Decoquinate (ethyl 6-decoxy-7-ethoxy-4-oxo-1H-quinoline-3-carboxylate) is an antiprotozoal agent. It acts against coccidia parasites and is thus known as a coccidiostat. Decoquinate-based products are majorly used in veterinary medicine. The global decoquinate-based products market is segmented on the basis of type of formulation, and geography. Decoquinate acts on the sporozoite stage of a coccidian parasite’s lifecycle. The sporozoite can penetrate the host’s intestinal call and prevents their further development, which necessitates the use of antiprotozoal substances. Decoquinate has low toxicity and is administered orally to a wide range of mammalian and avian species.
Key Reasons to Purchase:
• To gain insightful analyses of the market and have a comprehensive
understanding of the global Decoquinate-Based
Products market and its commercial landscape.
• Assess the production processes, major issues, and solutions to
mitigate the development risk.
• To understand the most affecting driving and restraining forces in the
Decoquinate-Based Products market and their impact in the global market.
• Learn about the Decoquinate-Based Products market strategies that are
being adopted by leading respective organizations.
• To understand the outlook and prospects for the market.
• Besides the standard structure reports, we also provide custom
research according to specific requirements.
Get
Free PDF Sample (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/decoquinate-based-products-market/request-sample
Various studies conducted on decoquinate-based products suggest that the
drug is readily tolerated by several target species including cattle and lambs.
On the other hand, studies conducted on rats and dogs showed minor changes in
food consumption, feed conversion, subdued behavior, and changes in body weight
and organ weight. In conclusion, though there may be a minor risk posed by
decoquinate-based products, the protection it provides against coccidian
parasites comfortably outweighs it.
On the basis of type of formulation, the global decoquinate-based
products market is segmented into powder, tablet, and nanoparticles and so on.
“Powdered decoquinate” dominates the global decoquinate-based products industry
owing to its ease of usage. Powdered decoquinate-based products can easily be
added to animal feed, which also helps the drug get absorbed into the animal’s
body at a rapid rate.
However, nanoscale decoquinate-based products comprise the fastest
growing segment of the global decoquinate-based products market due to the
added advantages nanoparticles provide over powders. The smaller size of
nanoparticles means they can be absorbed into the animal’s body even quicker
than powders. The increased overall surface area of nanoscale decoquinate-based
products also means they are more reactive and more likely to encounter a
coccidian parasite. On the basis of geography, the global decoquinate-based
products market is segmented into Asia Pacific, North America, Europe, Latin
America and Middle East & Africa.
North America and Europe currently dominate the global decoquinate-based
products market due to the strong economic conditions and the large population
of cattle in these regions. The Europe market for decoquinate-based products is
driven by the rising demand from Switzerland which is known for its large dairy
industry. Additionally, several
governments in North America and Europe have also set up regulatory agencies
which have also been instrumental in the growth of the global decoquinate-based
products market. These government bodies provide funds for developing novel
veterinary biologics and animal health products such as antibodies, vaccines,
diagnostic kits which are used for the prevention, diagnosis and treatment of
infectious diseases in animals.
The Asia Pacific market for decoquinate-based products is also growing
rapidly due to the increasing awareness about the benefits of decoquinate among
cattle and poultry breeders. The key players of global decoquinate-based
products market are Alpharma, Pfizer Inc., 3 nitro, ChlorMax, Albac,
Lincomusin, Laboratories Biove’s acti decocci and lacto decocci, Sogeval
Laboratories Rumicox, Pharmacia & Upjihn Company’s Lincomix and Qualian’s
Ucamix V decoquinate.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment